Assure Holdings Corp. (IONM)
USD 0.0
(-99.67%)
USD 0.0
(-99.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.43 Million USD | -23.07% |
| 2022 | 20.07 Million USD | 18.05% |
| 2021 | 17 Million USD | 43.89% |
| 2020 | 11.81 Million USD | 13.62% |
| 2019 | 10.39 Million USD | 62.88% |
| 2018 | 6.38 Million USD | -69.83% |
| 2017 | 21.16 Million USD | 36804.09% |
| 2016 | 57.35 Thousand USD | 102.87% |
| 2015 | 28.27 Thousand USD | -42.67% |
| 2014 | 49.3 Thousand USD | 23.01% |
| 2013 | 40.08 Thousand USD | -76.63% |
| 2012 | 171.52 Thousand USD | 175.7% |
| 2011 | 62.21 Thousand USD | -8.97% |
| 2010 | 68.34 Thousand USD | -23.14% |
| 2009 | 88.91 Thousand USD | 30.68% |
| 2008 | 68.04 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.91 Million USD | -49.16% |
| 2024 Q2 | 1.07 Million USD | -70.34% |
| 2023 Q3 | 3.54 Million USD | -1.55% |
| 2023 FY | 15.43 Million USD | -23.07% |
| 2023 Q1 | 3.52 Million USD | -52.67% |
| 2023 Q2 | 3.6 Million USD | 2.33% |
| 2023 Q4 | 7.69 Million USD | 116.77% |
| 2022 Q2 | 4.09 Million USD | -13.83% |
| 2022 Q3 | 3.35 Million USD | -18.1% |
| 2022 Q4 | 7.44 Million USD | 122.01% |
| 2022 Q1 | 4.75 Million USD | -5.23% |
| 2022 FY | 20.07 Million USD | 18.05% |
| 2021 Q4 | 5.01 Million USD | 34.76% |
| 2021 Q2 | 4.51 Million USD | 20.36% |
| 2021 Q3 | 3.72 Million USD | -17.63% |
| 2021 FY | 17 Million USD | 43.89% |
| 2021 Q1 | 3.75 Million USD | -14.57% |
| 2020 Q2 | 2.13 Million USD | -21.88% |
| 2020 Q4 | 4.39 Million USD | 71.9% |
| 2020 FY | 11.81 Million USD | 13.62% |
| 2020 Q1 | 2.73 Million USD | -30.21% |
| 2020 Q3 | 2.55 Million USD | 19.67% |
| 2019 Q3 | 2.13 Million USD | 7.86% |
| 2019 Q4 | 3.91 Million USD | 83.35% |
| 2019 FY | 10.39 Million USD | 62.88% |
| 2019 Q1 | 2.36 Million USD | 2.55% |
| 2019 Q2 | 1.98 Million USD | -16.35% |
| 2018 Q1 | 1.55 Million USD | -91.36% |
| 2018 FY | 6.38 Million USD | -69.83% |
| 2018 Q4 | 2.3 Million USD | 97.62% |
| 2018 Q3 | 1.16 Million USD | -13.56% |
| 2018 Q2 | 1.35 Million USD | -13.2% |
| 2017 Q3 | 1.12 Million USD | -17.18% |
| 2017 Q4 | 18.01 Million USD | 1494.55% |
| 2017 Q1 | 657.49 Thousand USD | 2631.47% |
| 2017 FY | 21.16 Million USD | 36804.09% |
| 2017 Q2 | 1.36 Million USD | 107.47% |
| 2016 Q4 | 24.07 Thousand USD | 28.29% |
| 2016 Q1 | 4462.88 USD | -46.2% |
| 2016 FY | 57.35 Thousand USD | 102.87% |
| 2016 Q2 | 10.43 Thousand USD | 133.84% |
| 2016 Q3 | 18.76 Thousand USD | 79.79% |
| 2015 Q3 | 7728.12 USD | 27.63% |
| 2015 FY | 28.27 Thousand USD | -42.67% |
| 2015 Q1 | 7039.75 USD | -38.26% |
| 2015 Q2 | 6054.89 USD | -13.99% |
| 2015 Q4 | 8296.02 USD | 7.35% |
| 2014 FY | 49.3 Thousand USD | 23.01% |
| 2014 Q3 | 8060.53 USD | -62.94% |
| 2014 Q4 | 11.4 Thousand USD | 41.47% |
| 2014 Q1 | 9144.37 USD | -52.04% |
| 2014 Q2 | 21.74 Thousand USD | 137.84% |
| 2013 Q1 | 9106.10 USD | -79.56% |
| 2013 FY | 40.08 Thousand USD | -76.63% |
| 2013 Q4 | 19.06 Thousand USD | 333.86% |
| 2013 Q3 | 4394.23 USD | -41.38% |
| 2013 Q2 | 7496.01 USD | -17.68% |
| 2012 FY | 171.52 Thousand USD | 175.7% |
| 2012 Q1 | 41.47 Thousand USD | 1.28% |
| 2012 Q2 | 56.22 Thousand USD | 35.56% |
| 2012 Q3 | 26.82 Thousand USD | -52.29% |
| 2012 Q4 | 44.55 Thousand USD | 66.1% |
| 2011 Q4 | 40.95 Thousand USD | 319.77% |
| 2011 Q1 | 6341.12 USD | -73.93% |
| 2011 Q2 | 5968.90 USD | -5.87% |
| 2011 Q3 | 9755.23 USD | 63.43% |
| 2011 FY | 62.21 Thousand USD | -8.97% |
| 2010 Q3 | 21.72 Thousand USD | 156.44% |
| 2010 FY | 68.34 Thousand USD | -23.14% |
| 2010 Q4 | 24.32 Thousand USD | 11.95% |
| 2010 Q2 | 8471.68 USD | -38.64% |
| 2010 Q1 | 13.8 Thousand USD | -76.67% |
| 2009 FY | 88.91 Thousand USD | 30.68% |
| 2009 Q4 | 59.17 Thousand USD | 892.07% |
| 2009 Q3 | 5965.01 USD | -27.16% |
| 2009 Q2 | 8188.98 USD | -34.98% |
| 2009 Q1 | 12.59 Thousand USD | 1217.01% |
| 2008 FY | 68.04 Thousand USD | 0.0% |
| 2008 Q3 | 20.73 Thousand USD | -53.28% |
| 2008 Q2 | 44.37 Thousand USD | 1072.17% |
| 2008 Q1 | 3786.07 USD | 0.0% |
| 2008 Q4 | 956.26 USD | -95.39% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 91.228% |
| Addus HomeCare Corporation | 248.92 Million USD | 93.798% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 86.952% |
| Amedisys, Inc. | 834.47 Million USD | 98.15% |
| American Oncology Network, Inc. | 83.97 Million USD | 81.615% |
| Astrana Health, Inc. | 112.59 Million USD | 86.288% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 97.371% |
| IMAC Holdings, Inc. | 5.02 Million USD | -207.114% |
| biote Corp. | 98.82 Million USD | 84.378% |
| Cryo-Cell International, Inc. | 35.2 Million USD | 56.146% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 95.428% |
| COMPASS Pathways plc | 136.91 Million USD | 88.724% |
| DocGo Inc. | 180.32 Million USD | 91.438% |
| The Ensign Group, Inc. | 335.39 Million USD | 95.397% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 91.835% |
| InnovAge Holding Corp. | 558.25 Million USD | 97.234% |
| The Joint Corp. | 109.22 Million USD | 85.865% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 96.857% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | 15.366% |
| ModivCare Inc. | 586.89 Million USD | 97.369% |
| NewGenIvf Group Limited | 1.63 Million USD | -841.665% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -14.313% |
| Option Care Health, Inc. | 666.62 Million USD | 97.684% |
| P3 Health Partners Inc. | 199.56 Million USD | 92.264% |
| P3 Health Partners Inc. | 199.56 Million USD | 92.264% |
| The Pennant Group, Inc. | 88.99 Million USD | 82.652% |
| Surgery Partners, Inc. | 319.5 Million USD | 95.168% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -259.088% |
| Talkspace, Inc. | 97.58 Million USD | 84.18% |
| Talkspace, Inc. | 97.58 Million USD | 84.18% |
| The Oncology Institute, Inc. | 136.59 Million USD | 88.697% |
| The Oncology Institute, Inc. | 136.59 Million USD | 88.697% |